Sanofi and SK bioscience have entered into a new chapter of their collaboration in pneumococcal vaccines with an expanded agreement to develop, license and commercialize next-generation PCVs for both ...

Moreover, BioNTech's partner Pfizer (PFE) for its COVID-19 vaccine has agreed to reimburse the company for up to $170 million of the claimed royalties payable to Penn for 2020-2023 sales in ...

Pursuant to the Project Agreement, the Company receives funding for a Phase 2b comparative study evaluating the Company’s oral pill XBB COVID-19 vaccine candidate against an mRNA vaccine ...

Take a look. Before embarking on a safari, travelers are hit with hidden costs. One major one is vaccines and medication. Vaccines and medications might be required for travel, depending on the ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

The 2014 outbreak in west Africa exposed a critical gap in global preparedness for infectious diseases: the absence of effective vaccines. There were no drugs or vaccines approved to treat or ...

Teva Pharmaceutical Industries Ltd. ADR 1.14% $25.35B ...

Can you get a vaccine to prevent all cancers? Reports in Russia’s state-run news agency claimed this week that Russian scientists have developed an mRNA vaccine that has shown the ability to suppress ...

This news category seems to be empty. Please return to the Home Page or read our Latest News.